Happy every time I see GRAPPA’s comprehensive treatment recommendations algorithm!
@APLAR_org @EMEUNET @GrappaO
🫰🏻And APLAR26 is officially OPEN!🫰🏻
#APLAR2026 #EULAR #ACR #eularEMEUNET
@EMEUNET @eular_org @APLAR_org
@milena_bond @dranielmar
🎤 Behind the scenes of APLAR-EULAR Exchange Programme 2026 with Professor Shin!
The ultimate question: Would he do it all over again? 👀
Stay tuned!
📍 서울, 대한민국 🇰🇷
📹 Camera courtesy of @dranielmar and @milena_bond!
#EMEUNET #EULAR #APLAR2026 @EMEUNET @eular_org
Lovely talks, everyone!!!
What a fantastic experience the EULAR–ACR–APLAR Exchange Programme has been!
@EMEUNET
@eular_org @APLAR_org @ACRheum
So happy to see TRIPOD-AI published in @bmj_latest led by @GSCollins.
Special thanks to @GSCollins and @TRIPODStatement for letting me participate in the TRIPOD-AI Delphi exercise.
NEW PAPER out today in @BMJ_latest TRIPOD+AI: reporting recommendations for studies developing or validating prediction models for use in healthcare that use #machinelearning methods
bmj.com/content/385/bmj-2023…
#ArtificialIntelligence #AIstandards #OpenAccess
Please share 🙏
ALT Screenshot of a new paper published in the BMJ "TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods"
Alex Garaiman retweeted
For the July #EUSTAR #YIGs Clinical #JC Dr. Alexandru Garaiman from University Hospital Zurich, selected the paper from Iudici et al highlighting the reasons for ineligibility in randomized controlled trials of systemic sclerosis patients. pubmed.ncbi.nlm.nih.gov/3398…
Alex Garaiman retweeted
Today starts the 1st webinar on #ILD in #SSc !! 🔜 the opening 👩⚕️👨⚕️📚 at 12.30 CET @sclerodermaUM @MatucciMarco @ShervinAssassi @lorenzodagna @hoffmann_vold @allanore @Worldsclerofnd 👀 to your participation !! worldsclerofound.org
Alex Garaiman retweeted
For the January Basic Science Journal Club, Dr. Burja from #EUSTAR YIGs have picked-up this interesting paper by Russo et al, showing epidermal dysfunction and howdysfunctional keratinocytes drive dermal inflammation in SSc
pubmed.ncbi.nlm.nih.gov/3349…
Alex Garaiman retweeted
Interesting paper about the #prevalence of systemic #lupus in the US 🇺🇲 Pooled prevalence was 72.8/100,000; 9x higher for 🚺 than 🚹 and highest among Black females (231), followed by Hispanic (121), white (85) and Asian/Pacific Islander females (84). doi.org/10.1002/art.41632
Alex Garaiman retweeted
Please share our new patient-telemedicine survey - mailchi.mp/88f43b9ce25d/may-…
Alex Garaiman retweeted
For the December Basic Science #EUSTAR YIGs Journal Club, Dr. Alain Lescoat selected this article by Gao et al. deciphering a pathogenic loop involving macrophages, immune complexes, osteopontin and IL-6 in SSc-ILD
pubmed.ncbi.nlm.nih.gov/3329…
Alex Garaiman retweeted
🆓🔹1ST International Symposium
on Interstitial Lung Disease
in Rheumatic Diseases🔹🎓
🎯Registration👇🏻 internationalild2021.virtual…
🤠 @sclerodermaUM
🤠 @MatucciMarco
🏡 @Worldsclerofnd
#SpreadTheWord #Scleroderma #Sjögren's #RheumatoidArthritis #Myositis #Lupus
Please join us for 1st international symposium on ILD in rheumatic dis on Feb 19-20, 2021. Symposium is free to attend with live discussion. Please join us! Thanks to all the sponors! worldsclerofound.org/wp-cont… @Worldsclerofnd @Boehringer @genentech @UMich @bmsnews @LillyRheumEU
Alex Garaiman retweeted
SALIVARY GLANDS INVOLVEMENT: A NEW INDICATOR OF JUVENILE IDIOPATHIC OLIGOARTICULAR ARTHRITIS! @RheumJnl Children with very low SFR (< 3.5 ml) exhibited a 16-fold higher likelihood of being affected by JIA1 rather than JIA2 (p = 0.003) tinyurl.com/y6okc7q5
Alex Garaiman retweeted
For the December #EUSTAR YIGs Jounal Club, Dr.Alexandru Garaiman recommended the study by Friedrich et al. which proposes the first composite score for prediction of digital ulcers in SSc patients: pubmed.ncbi.nlm.nih.gov/3253…
Alex Garaiman retweeted
NEW Viewpoint—@CosimoBruni and colleagues discuss the multifaceted problem of pulmonary arterial hypertension in #SystemicSclerosis thelancet.com/journals/lanrh… #LancetRheumatology #PAH
